# Treatment options for Friedreich ataxia
Friedreich ataxia has no cure, but in recent years several treatments have been developed that can slow symptoms or address certain aspects of the disease. This tab describes the regular and investigational phases of treatment, and how they work.
Antioxidants and mitochondrial support
Omaveloxolone ProveniIncluded in official guidelines, or approved by EMA or FDA
Omaveloxolone is a substance that helps cells against oxidative stress (harmful chemical reactions in the cell). It activates a protective protein (NRF2) in the cell, reducing inflammatory substances and allowing mitochondria (the energy factories of cells) to work better. In patients with Friedreich ataxia, omaveloxolone has been shown to slow the rate of decline in motor function (such as walking and coordination).
It is usually used as part of long-term treatment and is taken orally. Known side effects include abdominal discomfort, fatigue and elevation of certain blood values. The treatment requires regular blood tests.
Coenzyme Q10 ResearchediPositive results in clinical studies, not yet standard treatment
Coenzyme Q10 is a substance that occurs naturally in the body and is important for mitochondrial function. In some patients with Friedreich ataxia, modest improvements have been reported, but the evidence is less strong than for omaveloxolone. It is sometimes used, especially in earlier stages.
Gene stimulators and ion channel modulation
Sulforaphane ResearchediPositive results in clinical studies, not yet standard treatment
Sulforaphane is a natural substance from cruciferous vegetables (such as broccoli) that can protect cells against stress. In laboratory studies with cell cultures from patients with Friedreich ataxia, sulforaphane has shown protective effects on nerve cells. It is not yet standard treatment, but is undergoing studies.
Side effects are mild at regular doses; stomach complaints sometimes occur. It should not be used as a replacement for proven treatment.
Cardiac support
Cardiac Protection ProveniIncluded in official guidelines, or approved by EMA or FDA
Because Friedreich ataxia almost always affects the heart (thickened heart muscle and arrhythmias), treatment of heart problems is a central part of care. This includes:
- **Beta-blockers and ACE inhibitors**: these medications reduce the strain on the heart and slow heart muscle thickening. They are standard treatment and are adjusted for body weight and kidney function.
- **Medications for arrhythmias**: where applicable, to prevent irregular heart rate.
- **Regular cardiac examination**: via echocardiogram, ECG and sometimes MRI, to detect changes in the heart in time.
Many side effects of these medications (such as low blood pressure or fatigue) can occur, but should be initiated and monitored by the treating physician.
Muscle support and rehabilitation
Physiotherapy and exercise therapy ProveniIncluded in official guidelines, or approved by EMA or FDA
Regular guided exercise helps maintain muscle strength and coordination longer and can prevent falls. This includes:
- Structured exercise programs aimed at balance, strength and endurance
- Adapted movements as the disease progresses
- Instruction in safe use of walking aids
Effectiveness increases when it starts early in the disease process. Side effects are minimal, although fatigue can occur.
Speech and language support ProveniIncluded in official guidelines, or approved by EMA or FDA
As ataxia progresses, speech and swallowing can become difficult. Speech-language pathologists help with:
- Speech training to maintain clarity
- Evaluation of swallowing function
- Communication aids if necessary
This contributes to quality of life and nutrition.
Investigational phases of therapy
Gene therapy ExperimentaliOngoing in study setting, outcome still unknown
Various gene therapy approaches are under investigation:
- **SGT-212** and similar vectors: these deliver genetic material into cells to address the frataxin deficiency (the core problem of Friedreich ataxia).
- **CRISPR-based approach**: laboratory studies and animal models show that gene editing of mutations is theoretically possible, but has not yet reached human applications.
These therapies are in clinical trials. Because they directly address the genetic defect, they are potentially of great importance, but it is still unknown what long-term side effects may occur.
Stem Cell Transplantation Advised againstiProven ineffective or harmful, or dangerous in combination with your treatment
Earlier attempts with stem cell transplantation (especially in patients with concurrent blood cancers) have not yielded improvements in neurological symptoms, despite successful cancer treatment. This suggests that stem cells alone cannot achieve enough.
Iron control ResearchediPositive results in clinical studies, not yet standard treatment
Friedreich ataxia is accompanied by abnormal iron accumulation in the brain. Animal studies showed that limiting iron uptake in certain body parts can slow neurodegeneration. This is still in the precise research phase and is not routine treatment.
"Hypoxia in a pill" ExperimentaliOngoing in study setting, outcome still unknown
Recent animal studies show that certain medicines that affect the oxygen response of cells can reverse neurodegenerative manifestations in multiple models. This is still in a very early stage and has not yet been tested in humans.
Symptomatic support
Pain relief ProveniIncluded in official guidelines, or approved by EMA or FDA
Friedreich ataxia can be accompanied by bone abnormalities (especially scoliotic spine) and resulting pain. Treatment may include:
- Physical therapy
- Orthopedic aids (harness, support)
- Pain medication, if necessary under guidance
Treatment of diabetes manifestations ProveniIncluded in official guidelines, or approved by EMA or FDA
Up to 90% of patients with Friedreich ataxia develop glucose intolerance or diabetes. Treatment of this follows standard diabetes guidelines and is essential for heart and kidney health.
Not yet proven approaches
Nutritional supplements without evidence UnproveniNo scientific evidence that it works
Some supplements that are sometimes promoted (such as certain vitamins or herbal teas) have no clinical evidence of effectiveness in Friedreich ataxia. Discussion about this with your healthcare provider is important, because some supplements can interfere with medicines.
Points to consider when choosing treatment
- **Timing**: many treatments work better in earlier stages, before tissue is severely damaged.
- **Individual variation**: which substance helps and how quickly varies greatly from person to person.
- **Combination**: often multiple approaches are used at the same time (for example omaveloxolone with heart protection and physical therapy).
- **Regular monitoring**: because Friedreich ataxia affects many systems, appointments with neurologists, cardiologists and others are necessary.
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._